-
The U.S. federal agency said on Twitter that the stay temporarily suspends the marketing denial order while it conducts further review, but does not rescind it.
-
The Food and Drug Administration will have to decide the exact recipe, but a combination shot is expected that adds protection against a version of the omicron variant to the original vaccine.
-
The company "will finally be held accountable for creating the youth vaping epidemic," the advocacy group Parents Against Vaping e-cigarettes told NPR. Juul said it plans to fight the decision.
-
As the Food and Drug Administration weighs approval of COVID-19 vaccinations for children under age 5, Florida Surgeon General Joseph Ladapo is opposed to the potential change.
-
Advisers to the Food and Drug Administration overwhelmingly voted to recommend that it authorize Novavax's two-dose vaccine against COVID-19.
-
COVID-19 vaccinations for children younger than 5 could start right after the Juneteenth holiday.
-
The Centers for Disease Control and Prevention's advice opens a third COVID-19 shot to healthy elementary-age kids — just like what is already recommended for everybody 12 and older.
-
The Food and Drug Administration expanded authorization of Pfizer-BioNTech's COVID vaccine to enable kids ages 5 to 11 who were vaccinated at least five months ago to get a third shot.
-
Abbott, one of the largest formula makers in the U.S., has reached an agreement with the government to bring a closed factory back on line. And the FDA is easing some restrictions on imported formula.
-
The chance of dying after receiving the Janssen vaccine is about 1:2,000,000. But with multiple COVID-19 vaccines available, the FDA is limiting the use of the J&J vaccine.
-
The company says a low-dose version of its vaccine triggers an immune response in children ages 6 months to less than 6 years equivalent to what has protected older children and adults.
-
Data show that a third dose can help boost kids' immunity. Some experts are skeptical that another shot is needed for younger kids.